Floyd R. Sallee, MD, PhD
Ironshore Pharmaceuticals Inc., Durham, North Carolina
Original Research
Response and Remission with DR/ER-MPH
June 22, 2021
Delayed-release and extended-release methylphenidate (DR/ER-MPH) has shown marked improvement in ADHD symptoms and functional impairment. This post hoc analysis examined response and remission thresholds for DR/ER-MPH in the context...
